Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of sertindole in schizophrenia (SCoP 99824 continuation)
2007-002160-10Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sertindole in schizophrenia, sponsored by Lundbeck. Primary endpoint: Serious adverse events. Started Oct 2007; status: completed.
02
Drugs
sertindole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-002160-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002160-10.